ArticleJournal of fluorescence2026
Nitrogen-Doped Carbon Quantum Dots for FRET-Assisted and Smartphone-Enabled Fluorescent Detection of Melatonin in Biological Samples.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melatonin (N-acetyl-5-methoxytryptamine, MLT) is an endogenous neurohormone that regulates circadian rhythms, exhibits potent antioxidant activity, and has been implicated in cancer suppression and neuroprotection. In this study, we report the design and development of a highly sensitive optical nanosensor based on nitrogen-doped carbon quantum dots (N-CQDs) for the quantitative detection of MLT in human blood. The N-CQDs were synthesized via a facile pyrolysis route, yielding uniform nanodots that exhibit strong blue photoluminescence. Comprehensive structural, morphological, and optical characterizations were conducted using X-Ray Diffraction (XRD), transmission electron microscopy (TEM), and fluorescence spectroscopy, confirming the successful incorporation of nitrogen functionalities with a photoluminescence quantum yield of 36.6%. The synthesized N-CQDs exhibit a highly selective and sensitive detection towards MLT, and the sensing mechanism is plausibly governed by Förster resonance energy transfer (FRET)-mediated quenching of N-CQD emission upon interaction with MLT. This developed probe of N-CQDs achieved an impressive detection limit of 4.68 nM, demonstrating its potential for biomedical diagnostic applications. Furthermore, the system was successfully integrated into a smartphone-assisted sensing platform for portable and real-time MLT monitoring. Quantitative analysis of spiked human blood samples exhibited excellent recovery values ranging from 96.1% to 104.2%, validating the reliability and applicability of the proposed N-CQD-based sensor for clinical and point-of-care analysis.
Indexed as
Identifiers
42315719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.